Kimberly Freeman

Kimberly Freeman currently serves as Chief Strategy Officer at Zentalis Pharmaceuticals, a position held since July 2023. Previous roles include Vice President and Head of Oncology DDR Franchise at AstraZeneca from April 2021 to June 2023 and Vice President of Global Commercial at Adaptimmune from June 2016 to April 2021. Freeman has extensive experience in the oncology sector, having held positions such as Head of Oncology National Accounts at Boehringer Ingelheim and multiple roles at GlaxoSmithKline, including Director of Oncology Marketing and Senior Scientist. Academic qualifications include a Bachelor of Science in Biology from Cornell University, graduate studies in Human Biology at Cornell University, and education at The Wharton School.